ArticlePDF Available

Abstract and Figures

The present study was designed to determine whether consumption of an oral essential amino acid-carbohydrate supplement (EAC) before exercise results in a greater anabolic response than supplementation after resistance exercise. Six healthy human subjects participated in two trials in random order, PRE (EAC consumed immediately before exercise), and POST (EAC consumed immediately after exercise). A primed, continuous infusion of L-[ring-(2)H(5)]phenylalanine, femoral arteriovenous catheterization, and muscle biopsies from the vastus lateralis were used to determine phenylalanine concentrations, enrichments, and net uptake across the leg. Blood and muscle phenylalanine concentrations were increased by approximately 130% after drink consumption in both trials. Amino acid delivery to the leg was increased during exercise and remained elevated for the 2 h after exercise in both trials. Delivery of amino acids (amino acid concentration times blood flow) was significantly greater in PRE than in POST during the exercise bout and in the 1st h after exercise (P < 0.05). Total net phenylalanine uptake across the leg was greater (P = 0.0002) during PRE (209 +/- 42 mg) than during POST (81 +/- 19). Phenylalanine disappearance rate, an indicator of muscle protein synthesis from blood amino acids, increased after EAC consumption in both trials. These results indicate that the response of net muscle protein synthesis to consumption of an EAC solution immediately before resistance exercise is greater than that when the solution is consumed after exercise, primarily because of an increase in muscle protein synthesis as a result of increased delivery of amino acids to the leg.
Content may be subject to copyright.
Timing of amino acid-carbohydrate ingestion alters
anabolic response of muscle to resistance exercise
KEVIN D. TIPTON,
1,2
BLAKE B. RASMUSSEN,
1,2
SHARON L. MILLER,
1,2
STEVEN E. WOLF,
1
SHARLA K. OWENS-STOVALL,
1
BART E. PETRINI,
1
AND ROBERT R. WOLFE
1,2
1
Department of Surgery, University of Texas Medical Branch, and
2
Metabolism Unit,
Shriners Hospitals for Children, Galveston, Texas 77550
Received 5 September 2000; accepted in final form 6 March 2001
Tipton, Kevin D., Blake B. Rasmussen, Sharon L.
Miller, Steven E. Wolf, Sharla K. Owens-Stovall, Bart E.
Petrini, and Robert R. Wolfe. Timing of amino acid-car-
bohydrate ingestion alters anabolic response of muscle to
resistance exercise. Am J Physiol Endocrinol Metab 281:
E197E206, 2001.—The present study was designed to de-
termine whether consumption of an oral essential amino
acid-carbohydrate supplement (EAC) before exercise results
in a greater anabolic response than supplementation after
resistance exercise. Six healthy human subjects participated
in two trials in random order, PRE (EAC consumed immedi-
ately before exercise), and POST (EAC consumed immedi-
ately after exercise). A primed, continuous infusion of
L-[ring-
2
H
5
]phenylalanine, femoral arteriovenous catheterization,
and muscle biopsies from the vastus lateralis were used to
determine phenylalanine concentrations, enrichments, and
net uptake across the leg. Blood and muscle phenylalanine
concentrations were increased by 130% after drink con-
sumption in both trials. Amino acid delivery to the leg was
increased during exercise and remained elevated for the 2 h
after exercise in both trials. Delivery of amino acids (amino
acid concentration times blood flow) was significantly greater
in PRE than in POST during the exercise bout and in the 1st
h after exercise (P 0.05). Total net phenylalanine uptake
across the leg was greater (P 0.0002) during PRE (209 42
mg) than during POST (81 19). Phenylalanine disappear-
ance rate, an indicator of muscle protein synthesis from blood
amino acids, increased after EAC consumption in both trials.
These results indicate that the response of net muscle protein
synthesis to consumption of an EAC solution immediately
before resistance exercise is greater than that when the
solution is consumed after exercise, primarily because of an
increase in muscle protein synthesis as a result of increased
delivery of amino acids to the leg.
muscle protein synthesis; muscle protein breakdown; stable
isotopes; supplementation
BOTH EXERCISE AND NUTRITIONAL SUBSTRATES play impor-
tant roles in muscle protein metabolism. An acute bout
of resistance exercise increases muscle protein synthe-
sis more than breakdown, so that net muscle protein
balance (synthesis minus breakdown) is increased (5,
19, 20). Hyperaminoacidemia at rest has similarly
been demonstrated to increase net synthesis of muscle
protein, primarily by stimulating muscle protein syn-
thesis (1, 6). After intense resistance exercise, in-
creased amino acid availability via intravenous infu-
sion was shown to increase the rate of muscle protein
synthesis above levels observed with amino acid infu-
sion at rest (6). Thus exercise and amino acids seem to
have complementary effects on muscle protein synthe-
sis. Furthermore, the normal postexercise increase in
muscle protein breakdown was attenuated when
amino acids were infused after an exercise bout. Syn-
thesis, in this case, exceeded breakdown, resulting in
net muscle protein synthesis. Subsequently, we dem-
onstrated that a solution of amino acids given orally
was just as effective as intravenous amino acid infu-
sion for developing net muscle protein synthesis after
resistance exercise (27).
A combination of amino acids, to increase amino acid
availability, and carbohydrates, to stimulate insulin
release, should be a potent stimulator of net muscle
protein synthesis. We recently demonstrated that
ingestion of a bolus of6gofaminoacids combined
with 35 g of carbohydrates at both 1 and 3 h postex-
ercise resulted in muscle protein anabolism (21).
During an exercise bout, there may be a net loss of
muscle protein, because protein synthesis is either
decreased (8) or unchanged (9), whereas protein
breakdown is generally considered to be elevated (22).
Although muscle protein synthesis is increased after
exercise, it appears that this response is not stimulated
until some time after the exercise bout (17). Hyper-
aminoacidemia from ingestion of amino acids during
the exercise bout, as opposed to after exercise, may
counter the net loss of muscle protein, thereby creating
a more favorable situation for muscle growth. The
purpose of the present study was to determine whether
ingesting a combination of amino acid and carbohy-
drate before exercise is more effective in stimulating
net muscle protein synthesis than ingesting the mix-
ture after exercise.
Address for reprint requests and other correspondence: K. D.
Tipton, Metabolism Unit, Shriners Hospital for Children, 815 Mar-
ket St., Galveston, TX 77550 (E-mail: ktipton@utmb.edu).
The costs of publication of this article were defrayed in part by the
payment of page charges. The article must therefore be hereby
marked ‘‘advertisement’’ in accordance with 18 U.S.C. Section 1734
solely to indicate this fact.
Am J Physiol Endocrinol Metab
281: E197E206, 2001.
0193-1849/01 $5.00 Copyright
©
2001 the American Physiological Societyhttp://www.ajpendo.org E197
METHODS
Subjects
Six healthy volunteers (3 females, 3 males) were studied in
the postabsorptive state. The study design, purpose, and
possible risks were explained to each subject before written
consent was obtained. The Institutional Review Board and
the General Clinical Research Center (GCRC) of the Univer-
sity of Texas Medical Branch at Galveston approved the
study protocol. All subjects were healthy, nondiabetic, and
normotensive. They had a normal cardiac rhythm with no
abnormalities, as judged by medical history, physical exam-
ination, resting electrocardiogram, and laboratory blood and
urine tests. Subjects were recreationally active and were
instructed to refrain from physical exercise for 24 h before
being studied. Mean (SE) age was 30.2 3.1 yr, height was
1.71 0.03 m, weight was 66 6 kg, body mass index was
22 1 kg/m
2
, and leg volume was 9.78 0.61 liters. At least
1 wk before the initial infusion study, each subject was
familiarized with the leg press and leg extension machine,
and their one-repetition maximum (1RM, the maximum
weight that can be lifted for one repetition) was determined
on each. Mean 1RM for the leg press was 122.9 12.8 kg and
for the leg extension was 92.3 13.7 kg.
Experimental Protocol
The protocol was designed to determine whether an oral
amino acid-carbohydrate solution (EAC) would be a more
effective stimulator of muscle protein anabolism if given
immediately before or immediately after a resistance exer-
cise bout. Each subject participated in two trials in random
order. The response of muscle protein metabolism was deter-
mined during and after an intense resistance exercise bout
while each subject consumed, on separate occasions, a bolus
of EAC immediately before exercise (PRE) or immediately
after exercise (POST). Study days were separated by 2 mo.
Subjects were instructed to maintain a consistent dietary
intake pattern throughout the duration of the study. One
female subject completed only the PRE trial; thus all data
reflect means of six subjects for PRE and five subjects for
POST. A schematic representation of the study protocol is
shown in Fig. 1.
Subjects reported to the GCRC on the evening before each
study day and began fasting at 2200. After the overnight fast,
at 0600, an 18-gauge polyethylene catheter was inserted
into a large peripheral arm vein for the infusion of stable
isotopic tracers of amino acids. Catheters were inserted in
positions to prevent occlusion by bending of the arms. Sub-
jects were subsequently transported to the Exercise Metab-
olism Laboratory in the Shriners Hospital for Children,
Galveston. After background blood samples were taken, a
primed, continuous infusion of
L-[ring-
2
H
5
]phenylalanine
was started at 0630 and continued throughout the protocol.
The priming dose was 2 mol/kg, and the infusion rate was
0.05 mol min
1
kg
1
. Catheters were then placed in the
femoral artery and vein, as well as a second peripheral arm
vein contralateral to the infusion site. The femoral arterial
catheter was also used for the continuous infusion of indo-
cyanine green (ICG).
After2hofinfusion to establish an isotopic steady state,
resting measurements were made of amino acid concentra-
tions and enrichments in the femoral artery and vein, as well
as muscle. Three blood samples, separated by 10 min, were
taken from the femoral artery and vein for the measurement
of plasma arterial and venous amino acid enrichments and
concentrations. Blood samples were immediately placed into
preweighed tubes containing 1 ml of sulfosalicylic acid per
milliliter of blood and tubes containing lithium heparin. Leg
blood flow was measured by the dye-dilution technique dur-
ing this time (4). Briefly, ICG (0.5 mg/ml) was infused (60
ml/h) into the femoral artery. Blood samples were simulta-
neously taken from the femoral vein and a peripheral vein to
measure ICG concentration. The ICG infusion was briefly
halted and then quickly resumed to allow sampling from the
femoral artery for isotopic measurements. Immediately after
the blood sampling, a percutaneous muscle biopsy was taken
from the vastus lateralis. Muscle biopsies were taken from
the lateral portion of the vastus lateralis with sterile tech-
nique. The skin and subcutaneous tissue were anesthetized,
and an 6-mm incision was made in the skin and muscle
fascia. A 5-mm Bergstro¨m biopsy needle (Depuy, Warsaw,
IN), with the cutting window closed, was advanced 35 cm
through the fascia deep into the muscle. With suction ap-
plied, the cutting cylinder was opened and then closed 23
times. A sample of 50 mg of mixed muscle tissue was
obtained with each biopsy. Each sample was quickly (within
1 min) rinsed with ice-cold saline, blotted dry, and frozen in
liquid N
2
.
Immediately after the first muscle biopsy, subjects per-
formed an intense leg resistance exercise bout. Before initi-
ation of the resistance exercise routine, subjects consumed
either a 500-ml bolus of the EAC solution (PRE) or a placebo
solution (POST). The exercise bout consisted of 10 sets of 8
repetitions of leg press at 80% of 1RM and 8 sets of 8
repetitions of leg extension at 80% of 1RM. The rest interval
between sets was 2 min, and the entire exercise bout was
completed in 4550 min. Blood samples were taken from
the femoral artery and vein after the 4th and 8th sets of leg
press (10 and 20 min from the beginning of the exercise)
and the 2nd and 8th, or final, sets of leg extension (30 and
45 min from the beginning of the exercise). A second muscle
biopsy was taken in the rest interval between the 7th and 8th
sets of leg extension. A second bolus drink, placebo for the
PRE trial and EAC for the POST trial, was consumed imme-
diately after exercise and the final blood draw. A series of
arterial and venous blood samples and two muscle biopsies
were taken in the 2 h after exercise. Blood samples were
drawn at 10, 20, 30, 45, 60, 90, and 120 min after exercise.
Fig. 1. Schematic representation of the study protocol. Time values
are in minutes from the end of exercise. AV, arteriovenous; EX,
exercise; EAC, essential amino acid-carbohydrate (supplement); ring
d
5
-Phe, L-[ring-
2
H
5
]phenylalanine.
E198 ANABOLIC RESPONSE OF MUSCLE TO SUPPLEMENT TIMING
AJP-Endocrinol Metab VOL 281 AUGUST 2001 www.ajpendo.org
Muscle biopsies were taken at 55 and 115 min after exer-
cise and the ingestion of the 2nd bolus drink.
EAC Solution
Each subject consumed two 500-ml bolus drinks during
each trial. The order of the trials was randomly selected.
During the PRE trial, the EAC drink was consumed imme-
diately before initiation of the exercise bout, and the placebo
was consumed immediately upon cessation of the exercise
bout. For the POST trial, the order was reversed. The EAC
consisted of6gofessential amino acids, in amounts designed
to increase muscle free intracellular amino acid levels in
proportion to their respective requirements for protein syn-
thesis, and 35 g of sucrose in 500 ml of deionized-distilled
water. The amounts of essential amino acids in a 500-ml
bolus EAC solution were (mg and mol, respectively) histi-
dine 0.65, 4.2; isoleucine 0.60, 4.6; leucine 1.12, 8.5; lysine
0.93, 6.4; methionine 0.19, 1.3; phenylalanine 0.93, 5.6; thre-
onine 0.88, 7.4; and valine 0.7, 6.0. Additionally, 0.0605 g of
L-[ring-
2
H
5
]phenylalanine was added to the solution to main
-
tain isotopic steady state. A small amount of artificial sweet-
ener, containing aspartame, was added to the EAC to im-
prove palatability. The placebo solution was composed of
deionized-distilled water and an artificial sweetener contain-
ing aspartame. The placebo contained 200 mg of phenylal-
anine.
Analysis of Samples
Blood. Amino acid enrichment and concentration of phe-
nylalanine in whole blood were measured by gas chromatog-
raphy-mass spectrometry (GC-MS; model 5989B, Hewlett-
Packard, Palo Alto, CA) (18). Upon thawing, 500 lofthe
sulfosalicylic extract was passed over a cation exchange col-
umn (Dowex AG 50W-8X, 100200 mesh H form; Bio-Rad
Laboratories, Richmond, CA) and dried under vacuum using
a Speed Vac (Savant Instruments, Farmingdale, NY). To
determine the enrichment of infused amino acids in whole
blood, the tert-butyldimethylsilyl (t-BDMS) derivative of each
amino acid was made according to previously described pro-
cedures (5, 18, 19). Isotopic enrichments were determined by
GC-MS (model 5989B, Hewlett-Packard) and expressed as a
tracer-to-tracee ratio (t/T) (16). Concentrations of free amino
acids were determined using an internal standard solution,
as previously described (4, 5, 18, 19). The internal standard
used was
L-[ring-
13
C
6
]phenylalanine (50 mol/l) added in a
ratio of 100 l/ml of blood. Because the tube weight was
known, the amount of blood could also be determined, and
the blood amino acid concentration was determined from the
internal standard enrichments measured by GC-MS on the
basis of the amount of blood and internal standard added (4,
5, 18, 19). Appropriate corrections were made for overlapping
spectra that contributed to the t/T (23). Additionally, m5
enrichments were corrected 6% for contributions from m6.
Leg blood flow was determined by spectrophotometrically
measuring the ICG concentration in serum from the femoral
and the peripheral veins, as described previously (4, 5, 19).
Leg plasma flow was calculated from steady-state values of
dye concentration and converted to blood flow by use of the
hematocrit (4, 5, 18). Plasma insulin levels were determined
by radioimmunoassay (Diagnostic Products, Los Angeles,
CA). The intra-assay coefficient of variation (CV) was 1.45%.
Muscle. Muscle biopsy tissue samples were analyzed for
mixed protein-bound and free intracellular amino acid en-
richment and concentration, as previously described (4, 5, 18,
19). Tissue biopsies (50 mg) of the vastus lateralis were
immediately blotted and frozen in liquid N
2
. Samples were
then stored at 80°C until processed. Upon thawing, the
2530 mg of tissue were weighed and protein precipitated
with 0.5 ml of 10% perchloric acid. The tissue was then
homogenized and centrifuged, and the supernatant was col-
lected. This procedure was repeated two more times, and the
pooled supernatant (1.3 ml) was processed, as were the
blood samples described above in Blood. To determine intra-
cellular enrichment of infused tracers, the t-BDMS deriva-
tive was prepared as previously described (4, 5, 19) and
analyzed by GC-MS. Intracellular enrichment was deter-
mined by correction for extracellular fluid on the basis of the
chloride method (2). Muscle free amino acid concentration
was measured with the internal standard method, with cor-
rections for the contribution of extracellular fluid and for
overlapping spectra, as described previously (4, 5, 18, 19).
The remaining pellet of muscle tissue was further washed,
twice with 0.9% saline and three times with absolute ethanol.
It was then placed in an oven and dried at 50°C overnight.
The dried pellet was then hydrolyzed at 110°C for 24 h with
6 N HCl. The protein hydrolysate was then passed over a
cation exchange column and dried by Speed Vac derivatized
with t-BDMS, as described in Blood. Enrichment of protein-
bound
L-[ring-
2
H
5
]phenylalanine was determined by GC-MS
(model 5973, Hewlett-Packard) with a splitless injection and
positive electron impact ionization. Mass-to-charge ratios
(m/z ) 338 and 341 were monitored. These ions are the m3
and m5 enrichments, respectively, where m0 is the lowest
molecular weight of the ion. The ratio of m5/m3 was used
because it is more sensitive than the traditional m5/m 0
(used for blood samples). Enrichment from the protein-bound
samples was determined with a linear standard curve of
known m5/m 3 ratios and corrected back to the absolute
change in m5 enrichment over the incorporation period.
Calculations
Chemical net amino acid balance (NB) across the leg was
calculated from the difference between the femoral arterial
and venous concentrations multiplied by the blood flow. Thus
NB C
a
C
v
BF
where C
a
is arterial amino acid concentration, C
v
is venous
amino acid concentration, and BF is leg blood flow.
Area under the curve was used to calculate total, as well as
essential and nonessential, amino acid uptake (mg) across
the leg for a given time period. The resting value was used as
baseline, so that all values reflected the uptake due to inges-
tion of EAC. The amount of phenylalanine that was taken up
by the leg and utilized for protein synthesis was calculated by
C
m4
C
m1
C
m4m1
where C
m4
and C
m1
are the phenylalanine concentrations in
the intracellular pool of the final (4th) and initial (1st) muscle
biopsy. C
m4-m1
is the amount of phenylalanine remaining in
the muscle at the end of the study.
C
m4m1
LV 0.6 total Phe
where total Phe is the total amount of phenylalanine remain-
ing in the leg at the end of the study, LV is leg volume, and
0.6 is the volume of leg that is muscle (10).
uptake total Phe Phe for MPS
where uptake is uptake of phenylalanine across the leg, and
Phe for MPS is the amount of phenylalanine taken up by the
leg and utilized for muscle protein synthesis.
Because phenylalanine is not metabolized in muscle, mus-
cle protein synthesis and breakdown can be estimated using
E199ANABOLIC RESPONSE OF MUSCLE TO SUPPLEMENT TIMING
AJP-Endocrinol Metab VOL 281 AUGUST 2001 www.ajpendo.org
the NB across the leg and the arterial and venous enrich-
ments of
L-[ring-
2
H
5
]phenylalanine blood (26, 29). The rate of
appearance (R
a
) and rate of disappearance (R
d
)ofL-[ring-
2
H
5
]phenylalanine were calculated as estimations of muscle
protein breakdown and muscle protein synthesis, respec-
tively, from plasma amino acids in the blood (25, 29)
R
a
E
a
/E
v
1 Ca BF
where E
a
is arterial enrichment of L-[ring-
2
H
5
]phenyl-
alanine, E
v
is venous enrichment, and R
d
is NB R
a
.
R
a
,R
d
, and NB were calculated for four time periods by
combining the individual measurements within each period
and using the mean values in the calculations.
Data Presentation and Statistical Analysis
Data are presented as means SE. Results across time for
phenylalanine concentration were compared by one-way
ANOVA, with significance set at P 0.05. When the overall
P 0.05, Dunnett’s post hoc test was used to detect individ-
ual differences between rest and each time point. Differences
between PRE and POST for each time period and for total
phenylalanine uptake were detected with Student’s t-test
with unpooled variances, with significance set at P 0.05.
Leg blood flow, phenylalanine enrichment, R
a
,R
d
, NB,
delivery to the leg, and muscle concentration are presented
as means of four periods: Rest, Exercise, Hour 1 Postexercise,
and Hour 2 Postexercise. The model used to determine sta-
tistical differences for each of these variables (except for
muscle concentration) is of the form
Y
s,Tr,t
S
s
j 1
3
A
Tr,t
t
j
error
where s is 1,2,. . .,6 (S
s
is the effect of subject s), Tr is 0,1 (Tr
is the treatment, 0 is PRE, 1 is POST), t (the time period) is
1, 2, 3, or 4.
For muscle concentration, the model (which requires dele-
tion of the one subject who did not participate in the POST
part of the study) is
Y
s,Tr,t
S
s,Tr
j 1
3
A
Tr,t
t
j
error
This change was made because of the apparently large
change in baseline between PRE and POST studies for some
of the subjects. The object of the analysis is to determine in
which, if any, time periods (t 1, 2, 3, or 4) the conditions
j 1
3
A
0,t
t
j
j 1
3
A
1,t
t
j
are satisfied, and for
Tr 0, 1 and
which of the following hold
j 1
3
A
Tr,t
t
j
j 1
3
A
Tr,
j
and in those cases to obtain some idea of the magnitudes of
the change from the first to the second term. A general linear
model program was run with the measured data to address
these questions.
RESULTS
Blood Phenylalanine Concentrations
and Enrichments
Ingestion of EAC resulted in significant hyperami-
noacidemia in both the PRE and POST trials (Fig. 2).
Mean phenylalanine concentration increased by 67%
in the first 10 min of exercise and was significantly
increased over resting levels by 10 min after exercise
during the PRE trial. Phenylalanine concentration in-
creased further after cessation of exercise and peaked
30 min postexercise at levels 135% above basal.
Phenylalanine concentration declined from 30 min post-
exercise until 120 min postexercise. During POST,
mean phenylalanine concentration was unchanged
during exercise, increased significantly at 20 min post-
exercise, peaked at 130% of resting values 30 min
postexercise, and then declined steadily until 120 min
postexercise.
Mean enrichments of
L-[ring-
2
H
5
]phenylalanine are
presented as means of the four time periods in Table 1.
Arterial enrichment was decreased from rest during
exercise in both trials and in the 2nd h postexercise in
POST. Arteriovenous difference in enrichments was
decreased during exercise during both trials and dur-
ing the 1st h after exercise during PRE.
Fig. 2. Arterial and venous phenylalanine concentrations over time
for PRE trial (EAC before exercise, top) and POST trial (EAC after
exercise, bottom). *Significantly different from resting levels (time
55), P 0.05.
E200 ANABOLIC RESPONSE OF MUSCLE TO SUPPLEMENT TIMING
AJP-Endocrinol Metab VOL 281 AUGUST 2001 www.ajpendo.org
Muscle Phenylalanine Concentrations
Muscle intracellular free phenylalanine concentra-
tions are summarized in Fig. 3. Phenylalanine concen-
trations in muscle were significantly greater at rest
during the PRE trial than during POST. During PRE,
muscle phenylalanine concentration was increased
46% by the end of exercise and was further increased to
86% above basal levels 1 h after exercise. Two hours
after exercise, and thus 3 h after ingestion of EAC,
muscle phenylalanine concentrations were 65% above
basal. During POST, muscle phenylalanine concentra-
tions were not increased during exercise but were sig-
nificantly elevated above rest and exercise levels at 2 h
postexercise, i.e., 2 h after ingestion of EAC, respec-
tively. When the differences in resting values are ac-
counted for, muscle phenylalanine concentration was
not significantly different between PRE and POST at
any time point.
Blood Flow and Phenylalanine Delivery to the Muscle
Blood flow to the leg at rest was not different be-
tween treatments (Table 2). Resistance exercise signif-
icantly increased leg blood flow by 324% during PRE
and by 201% during POST. In the 1st h after exer-
cise, leg blood flow was still significantly elevated
above rest during both trials, but there was no differ-
ence from rest during the 2nd h. During exercise and in
the 1st h after exercise, leg blood flow was significantly
greater for PRE than for POST.
Amino acid delivery to the leg (C
a
BF) at rest was
not significantly different between trials (Table 2).
During exercise, delivery was increased by 650% in
the PRE trial and by almost 250% in the POST trial.
Delivery remained elevated above resting levels during
the 1st h after exercise for both trials but was not
increased in the 2nd h postexercise. Phenylalanine
delivery to the muscle was greater in PRE than POST
during exercise and the 1st h after exercise.
Plasma Insulin
Arterial insulin values for each time period are
shown in Table 3. Insulin levels significantly increased
after EAC consumption in each trial, i.e., during exer-
cise for PRE and immediately after exercise for POST.
Insulin remained elevated during the 1st h postexer-
cise in PRE and returned to resting levels by the 2nd h
postexercise in both trials.
Phenylalanine Uptake Across the Leg
Figure 4 shows the net phenylalanine uptake across
the leg measured over 3 h for the PRE and POST trials.
Net uptake of phenylalanine was 160% greater in
PRE than in POST during the entire 3 h. The percent-
age of ingested phenylalanine that was taken up by the
leg was almost threefold greater (P 0.01) during PRE
(21 4%) than during POST (8 2%), or 42 8 vs.
16 4% for PRE vs. POST, respectively, for both legs.
More phenylalanine remained in the muscle intracel-
lular pool of the leg at the end of the study in POST
than in PRE (P 0.04; 24 3 and 42 8 for PRE and
POST, respectively). Thus, over the3hofthestudy,
180 50 mg of phenylalanine were taken up and
incorporated into protein during PRE and 39 18 mg
during POST (P 0.02).
When these values are calculated for only the final
2 h of each trial, the differences narrow from the full
3 h and do not reach statistical significance, but the
trend for PRE values to be greater than POST remains.
Phenylalanine uptake for only the 2 h postexercise was
243 120 mg phenylalanine for PRE and 130 45 mg
phenylalanine for POST (P 0.19). The mean percent-
age of ingested phenylalanine taken up by one leg in
the final 2 h postexercise only was 80% greater during
PRE (25 12%) than during POST (13 5%; P
Table 1. Mean arterial and venous phenylalanine enrichments and arteriovenous difference in enrichments
in PRE and POST trials
Rest Exercise 1 H Post-Ex 2 H Post-Ex
Artery PRE 0.08840.0134 0.07240.0084* 0.06910.0092 0.07590.0126
POST 0.0886 0.0165 0.0687 0.0108* 0.0664 0.0117 0.0691 0.121*
Vein PRE 0.06550.0087 0.06800.0078 0.06410.0079 0.06670.0092
POST 0.0656 0.0118 0.0643 0.0099 0.0598 0.0106 0.0601 0.0100
a-v Difference PRE 0.01510.0072 0.00440.0011* 0.00540.0018* 0.00920.0038
POST 0.0230 0.0049 0.0044 0.0010* 0.0067 0.0011 0.0090 0.0022
Values are enrichments SE, expressed as tracer-to-tracee ratio (t/T). a-v, arteriovenous; PRE, value when essential amino acid-
carbohydrate (EAC) drink was consumed before exercise. POST, value when EAC was consumed after exercise. Rest, mean value for resting
time period. Exercise, mean value during exercise bout. 1 H Post-Ex, mean value for samples taken 060 min after exercise bout. 2 H Post-Ex,
mean value for samples taken 60120 min after exercise bout. *Significantly different from Rest, P 0.05.
Fig. 3. Muscle free intracellular concentration (IC) of phenylalanine
for 4 muscle biopsies during PRE and POST trials. *Significantly
different from biopsy 1 (rest), P 0.05.
E201ANABOLIC RESPONSE OF MUSCLE TO SUPPLEMENT TIMING
AJP-Endocrinol Metab VOL 281 AUGUST 2001 www.ajpendo.org
0.20). Similarly, the mean amount of phenylalanine
taken up during the final 2 h after EAC ingestion (i.e.,
during exercise and the 1st h after exercise for PRE
and the 2 h after exercise for POST) in each trial was
195 37 mg for PRE and 130 45 for POST, P 0.14.
Phenylalanine Kinetics
Figure 5 summarizes phenylalanine R
a
,R
d
, and NB
for each time period during PRE and POST trials.
Phenylalanine R
a
did not change significantly from
resting levels during or after exercise in either PRE or
POST. PRE and POST R
a
values were not statistically
different at any time point. R
d
increased from Rest in
the hour immediately after EAC consumption by 216%
during PRE (exercise) and by 60% during POST (1st h
after exercise) trials. PRE R
d
was significantly greater
than POST R
d
during exercise and in the 1st h after
exercise. R
d
was not different for PRE and POST in the
2nd h after exercise.
During PRE, NB changed from negative at rest to
positive values during exercise and the 1st h postexer-
cise. During POST, NB was negative at rest and during
exercise but increased to positive values after exercise,
when the EAC drink was consumed. NB during POST
immediately returned to zero in the 2nd h after exer-
cise. NB was significantly greater during exercise and
in the 1st h after exercise in the PRE trial than in the
POST trial.
DISCUSSION
This study was designed to determine whether the
response of muscle protein metabolism to an EAC
solution was different if consumed immediately before
resistance exercise rather than immediately after re-
sistance exercise. Ingestion of EAC changed net muscle
protein balance from negative values, i.e., net release,
to positive net uptake, in both trials. However, the
total response to the consumption of EAC immediately
before exercise was greater than the response when
EAC was consumed immediately after exercise. Fur-
thermore, it appears that the change from a catabolic
state in the muscle to an anabolic state was primarily
due to an increase in muscle protein synthesis.
In the present study, the effectiveness of the drink
appeared to be greater when it was consumed imme-
diately before exercise (PRE) compared with immedi-
ately after exercise (POST). Approximately 209 42
mg of phenylalanine were taken up across the leg in
the PRE trial, whereas only 81 19 mg of phenylala-
nine were taken up during POST. Whereas the re-
sponse of muscle protein metabolism increased dra-
matically and then declined within1htobasal levels
after EAC consumption in the POST trial, the response
was sustained in the PRE trial. Net balance increased
during exercise, declined slightly, and then increased a
second time after exercise when the drink was con-
sumed before exercise. The length of the effect, plus
higher blood flow during exercise in the PRE trial,
resulted in significantly greater total uptake over the
entire study period.
In this study, the primary end point was to examine
the impact of the timing of EAC ingestion in relation to
resistance exercise on net muscle protein synthesis
and, as a result, the accretion of muscle. Thus the
response over the entire 3-h study period is the most
appropriate to compare between trials. On the other
hand, it could be argued that the results are biased
toward the PRE trial by calculating the data over the
entire 3-h study period. During PRE, the entire 3 h
follows the consumption of EAC, whereas during
POST, only 2 of the 3 h follow EAC ingestion. As a
result, we also calculated the uptake across the leg
over only the final 2 h after exercise of each trial, i.e.,
the 2nd and 3rd h after EAC ingestion during PRE and
the 1st and 2nd h after EAC ingestion during POST.
Calculated this way, the gap between the trials nar-
rowed, but the mean uptake across the leg was still
Fig. 4. Net phenylalanine uptake across the leg over 3 h for PRE and
POST trials. *Significantly different from POST (P 0.013).
Table 2. Mean blood flow and delivery of phenylalanine to the leg for PRE and POST trials
Rest Exercise 1 H Post-Ex 2 H Post-Ex
Blood flow, ml min
1
100 ml LV
1
PRE 4.590.58 19.462.24* 7.641.73* 5.14 0.74
POST 3.670.46 11.051.28*† 4.720.36*† 3.350.32
Phe delivery, nmol min
1
100 ml LV
1
PRE 25332 1,890 396* 828129* 539 80
POST 19128 65480*† 506 97*† 34159
Values are means SE. Delivery of phenylalanine to the leg is calculated by blood flow arterial concentration. LV, leg volume.
*Significantly different from Rest, P 0.05. Significantly different from corresponding PRE value, P 0.05.
Table 3. Mean arterial insulin levels during 4 time
periods for PRE and POST trials
Rest Exercise 1 H Post-Ex 2 H Post-Ex
PRE 4.50.5 18.5 5.7 22.06.2 6.22.0
POST 4.10.8 8.52.4 27.0 5.8 6.6 1.2
Values are means SE, expressed in IU/ml. Both PRE and POST
were significantly different across time, but individual significant
differences were not identifiable.
E202 ANABOLIC RESPONSE OF MUSCLE TO SUPPLEMENT TIMING
AJP-Endocrinol Metab VOL 281 AUGUST 2001 www.ajpendo.org
80% greater for PRE than for POST (244 120 mg vs.
130 45 mg, respectively), although the difference did
not reach statistical significance (P 0.09). If any-
thing, comparing only the final2hofeach trial biases
the results toward favoring the POST trial, because the
1st h after consumption of EAC during PRE is ignored.
Nonetheless, it is still evident that consuming EAC
before exercise is more effective than after exercise.
Fig. 5. Muscle phenylalanine rate of appearance
from muscle (R
a
), phenylalanine uptake from blood
(R
d
), and net phenylalanine balance across leg
(NB) for 4 time periods during PRE (open bars) and
POST (solid bars). Rest, mean of 3 resting values.
Ex, mean of 4 samples taken during resistance
exercise. Hr 1 PE, mean of 4 samples taken during
the 1st h after exercise. Hr 2 PE, mean of 3 sam-
ples taken during the 2nd h after exercise. *PRE
significantly different from POST, P 0.05.
E203ANABOLIC RESPONSE OF MUSCLE TO SUPPLEMENT TIMING
AJP-Endocrinol Metab VOL 281 AUGUST 2001 www.ajpendo.org
Effectiveness of the timing of EAC ingestion is sup-
ported by comparing the amount of phenylalanine
taken up by the leg to the amount ingested in each
trial. During PRE, 21% of ingested phenylalanine
was taken up by the leg, thus 42% by both legs. The
proportion was much lower during POST, 8% across
one leg or 16% for both legs. When EAC was consumed
1 h after exercise, 125 mg of phenylalanine were
taken up across the leg (21), or about one-half of the
value found when EAC was consumed before exercise.
This represented 11% of the ingested phenylalanine
for one leg, or 22% for both legs. When amino acids
were infused over a 3-h period after exercise, 34% of
the infused amino acids were taken up across both legs
(6). Clearly, EAC consumption before exercise is more
effective than after exercise.
These data do not allow us to determine definitively
the reasons for the greater response of net muscle
protein synthesis to consuming essential amino acids
plus carbohydrates immediately before exercise rather
than after exercise. However, it is likely that the
greater delivery of amino acids to the muscle during
PRE accounts for the greater net uptake than during
POST. During exercise in the POST trial, net muscle
protein balance, as well as phenylalanine R
d
, an index
of muscle protein synthesis, was unchanged, whereas
in the PRE trial, phenylalanine R
d
and NB were in
-
creased. Consuming a source of amino acids before
exercise increases amino acid availability. Providing
amino acids at a time when blood flow is elevated, such
as during the exercise bout, maximizes delivery to the
muscle. Previous studies have demonstrated that mus-
cle protein synthesis is related to amino acid delivery
to the leg (5, 6, 27). Phenylalanine delivery during
exercise in the PRE trial was increased 6.5-fold over
resting levels and was more than twice that of POST.
Furthermore, delivery remained elevated after exer-
cise during PRE to a significantly greater extent above
that during POST. Similarly, in our previous study,
amino acid delivery was increased by EAC ingestion at
both 1 and 3 h postexercise (21) to levels comparable to
those obtained when EAC was consumed immediately
after exercise. Thus consumption of amino acids before
exercise results in greater amino acid delivery than
when they are consumed at various time points after
exercise, likely accounting for the greater response of
net muscle protein synthesis demonstrated during the
PRE trial.
Previously, we showed that hyperaminoacidemia
elicited by intravenous infusion of mixed amino acids
(6) and oral ingestion of both mixed and essential
amino acids (27) resulted in net muscle protein synthe-
sis after resistance exercise. In these studies, 40gof
amino acids were provided steadily over a 3-h period.
We also demonstrated that nonessential amino acids
are unnecessary to stimulate net muscle protein syn-
thesis at rest (28) or after exercise (27). Subsequently,
we examined the response of muscle protein metabo-
lism to ingestion of a smaller amount of essential
amino acids plus carbohydrates (21) identical to the
one used in the present study. Similar levels of net
muscle protein synthesis resulted when subjects con-
sumed the bolus amino acid-carbohydrate solution at
both 1 and 3 h after exercise (21). Taken together with
the present results, it is clear that a relatively small
amount of essential amino acids, combined with carbo-
hydrates, is a potent stimulator of net muscle protein
synthesis when given either before or at various times
after resistance exercise.
It is not possible to delineate the effectiveness of the
separate components of the drink from this study. We
have previously demonstrated that muscle protein syn-
thesis is stimulated by essential amino acids alone (27,
28). Even single essential amino acids in a flooding
dose may stimulate muscle protein synthesis (24). It is
more difficult to assign a role to insulin in the change
from net negative protein balance to positive protein
balance. After exercise, insulin seems to be necessary
for protein synthesis to occur (11, 12, 14), yet increased
insulin does not stimulate muscle protein synthesis (7).
However, elevated insulin after resistance exercise
does diminish the increase of muscle protein break-
down in response to exercise (7). Consistent with this
notion, during the present study, phenylalanine R
a
,an
index of muscle protein breakdown, did not increase
after exercise in either trial. Thus stimulation of mus-
cle protein synthesis by essential amino acids, in addi-
tion to inhibition of the normal postexercise rise in
breakdown, likely accounts for the effectiveness of the
EAC drink for stimulating net muscle protein synthe-
sis after resistance exercise.
Determination of the response of the muscle in the
present study is based primarily on uptake of phenyl-
alanine across the leg. It is assumed that phenylala-
nine uptake corresponds to accretion of muscle protein.
However, it is possible that all of the amino acids taken
up by the muscle are not incorporated into protein, but
instead some fraction of the uptake simply expands the
muscle free intracellular pool. The amino acids could
then be released at some time after the conclusion of
the measurements, without ever being utilized for
muscle protein synthesis. Thus it is possible that net
uptake overestimated the extent of net muscle protein
synthesis. However, even if we assume the unlikely
circumstance that all of the phenylalanine remaining
in the muscle intracellular pool at the conclusion of the
study would be subsequently released, the amount
does not appear to be a substantial proportion of that
taken up by muscle, especially in the PRE trial. During
PRE, 24 3 mg of phenylalanine were taken up by
muscle but not utilized for protein synthesis, in con-
trast to 42 8 mg during POST. Thus the total amount
of phenylalanine taken up by the leg and utilized for
protein synthesis was 180 mg (86% of total uptake)
during PRE and 39 mg (48% of total uptake) during
POST. Clearly, even with this conservative estimate, a
large proportion of the phenylalanine taken up by
muscle was, in fact, utilized for muscle protein synthe-
sis during the study, further supporting the notion that
the EAC solution is an effective stimulator of muscle
protein anabolism.
E204
ANABOLIC RESPONSE OF MUSCLE TO SUPPLEMENT TIMING
AJP-Endocrinol Metab VOL 281 AUGUST 2001 www.ajpendo.org
In the fasted state, muscle protein breakdown ex-
ceeds muscle protein synthesis, resulting in a net neg-
ative muscle protein balance. Net positive muscle pro-
tein balance can result only from an increase in muscle
protein synthesis and/or a decrease in muscle protein
breakdown. Resistance exercise alone has been shown
to increase muscle protein synthesis, but breakdown is
also increased, such that net muscle protein balance
remains negative (5). Additionally, net muscle protein
synthesis as a consequence of hyperaminoacidemia af-
ter resistance exercise is primarily due to increased
muscle protein synthesis (6, 27). In our previous study,
increased muscle protein synthesis was responsible for
the change from a catabolic to an anabolic state after
ingestion of EAC at both 1 and 3 h postexercise (21).
Similarly, in the present study, it is likely that the
increase in NB from negative to positive after EAC
consumption in both trials was also primarily due to an
increase in muscle protein synthesis. Mean R
d
, i.e.,
uptake of amino acids from the plasma pool, increased
dramatically (216 and 200% for PRE and POST, re-
spectively) after ingestion of EAC. The fact that phe-
nylalanine R
a
, an indicator of muscle protein break
-
down, did not change in response to EAC ingestion
further supports the notion that the change of net
muscle protein balance from positive to negative is
primarily due to an increase in protein synthesis.
In the present study, our arteriovenous tracer meth-
odology has quantified only the fate of blood-borne
amino acids (25, 29). Because the incorporation of
amino acids from the EAC solution into muscle protein
was of primary interest, R
d
and R
a
calculated using
blood-borne amino acids seemed the most appropriate
measures. In past studies we have utilized a three-
compartment model of muscle protein metabolism to
describe the effects of nutrition and exercise on muscle
protein synthesis and breakdown (3, 5, 6, 14, 15, 27).
However, in the present study, the combination of
sampling in close proximity to exercise and a bolus
ingestion of amino acids has made the use of that
model problematic. That model requires an isotopic
and physiological steady state, as well as a measurable
gradient between blood and intracellular phenylala-
nine enrichment. Instead, we calculated R
a
and R
d
by
use of data only from blood (25, 29). Whereas care must
be taken in interpreting R
a
and R
d
values from this
model (3, 30), it is the appropriate model to use in the
present study. The importance of the plasma amino
acids as a source for muscle protein synthesis is em-
phasized in this study. Therefore utilization of R
d
was
the appropriate parameter with which to compare the
effects of the timing of ingestion of the EAC drink.
Moreover, utilization of the blood-borne precursor for
measurement of R
d
allows us to relate these values to
net muscle protein synthesis determined by phenylal-
anine uptake.
The ingestion of a relatively small amount of essen-
tial amino acids, combined with carbohydrates, is an
effective stimulator of net muscle protein synthesis.
The stimulation of net muscle protein synthesis when
EAC is consumed before exercise is superior to that
when EAC is consumed after exercise. The combina-
tion of increased amino acid levels at a time when blood
flow is increased appears to offer the maximum stim-
ulation of muscle protein synthesis by increasing
amino acid delivery to the muscle and thus amino acid
availability.
We thank the nurses and staff of the General Clinical Research
Center (GCRC) at the University of Texas Medical Branch in
Galveston, TX. We also thank Dr. J. Rosenblatt for statistical assis-
tance, and the volunteers who participated in the studies for their
time and hard work.
This work was supported in part by Grants 8940 and 15489 from
the Shriners Hospitals for Children and National Institutes of
Health (NIH) Grant R01–38010. Studies were conducted at the
GCRC at the University of Texas Medical Branch at Galveston,
which is funded by a grant (M01 RR-00073) from the National Center
for Research Resources, NIH.
REFERENCES
1. Bennet WM, Connacher AA, Scrimgeour CM, Smith K, and
Rennie MJ. Increase in anterior tibialis muscle protein synthe-
sis in healthy man during mixed amino acid infusion: studies of
incorporation of [1-
13
C]leucine. Clin Sci (Colch) 76: 447454,
1989.
2. Bergstro¨ m J, Furst P, Noree LO, and Vinnars E. Intracel-
lular free amino acid concentration in human muscle tissue.
J Appl Physiol 36: 693697, 1974.
3. Biolo G, Chinkes D, Zhang XJ, and Wolfe RR. Harry M. Vars
Research Award. A new model to determine in vivo the relation-
ship between amino acid transmembrane transport and protein
kinetics in muscle. J Parenter Enteral Nutr 16: 305315, 1992.
4. Biolo G, Fleming RY, Maggi SP, and Wolfe RR. Transmem-
brane transport and intracellular kinetics of amino acids in
human skeletal muscle. Am J Physiol Endocrinol Metab 268:
E75E84, 1995.
5. Biolo G, Maggi SP, Williams BD, Tipton KD, and Wolfe RR.
Increased rates of muscle protein turnover and amino acid trans-
port after resistance exercise in humans. Am J Physiol Endocri-
nol Metab 268: E514E520, 1995.
6. Biolo G, Tipton KD, Klein S, and Wolfe RR. An abundant
supply of amino acids enhances the metabolic effect of exercise
on muscle protein. Am J Physiol Endocrinol Metab 273: E122
E129, 1997.
7. Biolo G, Williams BD, Fleming RY, and Wolfe RR. Insulin
action on muscle protein kinetics and amino acid transport
during recovery after resistance exercise. Diabetes 48: 949957,
1999.
8. Bylund-Fellenius AC, Ojamaa KM, Flaim KE, Li JB, Wass-
ner SJ, and Jefferson LS. Protein synthesis versus energy
state in contracting muscles of perfused rat hindlimb. Am J
Physiol Endocrinol Metab 246: E297E305, 1984.
9. Carraro F, Stuart CA, Hartl WH, Rosenblatt J, and Wolfe
RR. Effect of exercise and recovery on muscle protein synthesis
in human subjects. Am J Physiol Endocrinol Metab 259: E470
E476, 1990.
10. Dempster WT and Gaughran GRL. Properties of body seg-
ment based on size and weight. Am J Anat 120: 3354, 1965.
11. Farrell PA, Fedele MJ, Vary TC, Kimball SR, Lang CH,
and Jefferson LS. Regulation of protein synthesis after acute
resistance exercise in diabetic rats. Am J Physiol Endocrinol
Metab 276: E721E727, 1999.
12. Fedele MJ, Hernandez JM, Lang CH, Vary TC, Kimball
SR, Jefferson LS, and Farrell PA. Severe diabetes prohibits
elevations in muscle protein synthesis after acute resistance
exercise in rats. J Appl Physiol 88: 102108, 2000.
13. Ferrando AA, Tipton KD, Doyle D, Phillips SM, Cortiella
J, and Wolfe RR. Testosterone injection stimulates net protein
synthesis but not tissue amino acid transport. Am J Physiol
Endocrinol Metab 275: E864E871, 1998.
E205ANABOLIC RESPONSE OF MUSCLE TO SUPPLEMENT TIMING
AJP-Endocrinol Metab VOL 281 AUGUST 2001 www.ajpendo.org
14. Fluckey JD, Vary TC, Jefferson LS, and Farrell PA. Aug-
mented insulin action on rates of protein synthesis after resis-
tance exercise in rats. Am J Physiol Endocrinol Metab 270:
E313E319, 1996.
15. Forslund AH, Hambraeus L, Olsson RM, El-Khoury AE, Yu
YM, and Young VR. The 24-h whole body leucine and urea
kinetics at normal and high protein intakes with exercise in
healthy adults. Am J Physiol Endocrinol Metab 275: E310
E320, 1998.
16. Gannon MC, Nuttall FQ, Krezowski PA, Billington CJ, and
Parker S. The serum insulin and plasma glucose response to
milk and fruit products in type 2 (non-insulin-dependent) dia-
betic patients. Diabetolgia 29: 784791, 1986.
17. Hernandez JM, Fedele MJ, and Farrell PA. Time course
evaluation of protein synthesis and glucose uptake after acute
resistance exercise in rats. J Appl Physiol 88: 11421149, 2000.
18. Meredith CN, Frontera WR, Fisher EC, Hughes VA, Her-
land JC, Edwards J, and Evans WJ. Peripheral effects of
endurance training in young and old subjects. J Appl Physiol 66:
28442849, 1989.
19. Phillips SM, Tipton KD, Aarsland A, Wolf SE, and Wolfe
RR. Mixed muscle protein synthesis and breakdown after resis-
tance exercise in humans. Am J Physiol Endocrinol Metab 273:
E99E107, 1997.
20. Phillips SM, Tipton KD, Ferrando AA, and Wolfe RR.
Resistance training reduces the acute exercise-induced increase
in muscle protein turnover. Am J Physiol Endocrinol Metab 276:
E118E124, 1999.
21. Rasmussen BB, Tipton KD, Miller SL, Wolf SE, and Wolfe
RR. An oral essential amino acid-carbohydrate supplement en-
hances muscle protein anabolism after resistance exercise.
J Appl Physiol 88: 386392, 2000.
22. Rennie MJ, Edwards RH, Krywawych S, Davies CT, Hal-
liday D, Waterlow JC, and Millward DJ. Effect of exercise on
protein turnover in man. Clin Sci (Colch) 61: 627639, 1981.
23. Rosenblatt J, Chinkes D, Wolfe M, and Wolfe RR. Stable
isotope tracer analysis by GC-MS, including quantification of
isotopomer effects. Am J Physiol Endocrinol Metab 263: E584
E596, 1992.
24. Smith K, Reynolds N, Downie S, Patel A, and Rennie MJ.
Effects of flooding amino acids on incorporation of labeled amino
acids into human muscle protein. Am J Physiol Endocrinol
Metab 275: E73E78, 1998.
25. Thompson GN, Pacy PJ, Ford GC, and Halliday D. Practi-
cal considerations in the use of stable isotope labelled com-
pounds as tracers in clinical studies. Biomed Environ Mass
Spectrom 18: 321327, 1989.
26. Thompson GN, Pacy PJ, Merritt H, Ford GC, Read MA,
Cheng KN, and Halliday D. Rapid measurement of whole body
and forearm protein turnover using a [
2
H
5
]phenylalanine model.
Am J Physiol Endocrinol Metab 256: E631E639, 1989.
27. Tipton KD, Ferrando AA, Phillips SM, Doyle D Jr, and
Wolfe RR. Postexercise net protein synthesis in human muscle
from orally administered amino acids. Am J Physiol Endocrinol
Metab 276: E628E634, 1999.
28. Tipton KD, Gurkin BE, Matin S, and Wolfe RR. Nonessen-
tial amino acids are not necessary to stimulate net muscle
protein synthesis in healthy volunteers. J Nutr Biochem 10:
8995, 1999.
29. Wolfe RR. Radioactive and Stable Isotope Tracers in Biomedi-
cine: Principles and Practice of Kinetic Analysis. New York:
Wiley-Liss, 1992.
30. Wolfe RR. Effects of insulin on muscle tissue. Curr Opin Clin
Nutr Metab Care 3: 6771, 2000.
E206 ANABOLIC RESPONSE OF MUSCLE TO SUPPLEMENT TIMING
AJP-Endocrinol Metab VOL 281 AUGUST 2001 www.ajpendo.org
... Research demonstrates that CHO ingestion alone, or combined with PRO, pre-and/or post-exercise improves net muscle balance, thus providing a basis for the hypothesis that nutritive intervention around the time of resistance exercise will positively impact the skeletal muscle hypertrophic adaptation to training [22,52,54]. Roy and colleagues found that CHO supplementation (1.0 g/kg) immediately and 1 h after unilateral knee extensor exercise (8 sets × 10 repetitions 85% 1-RM) significantly increased insulin and glucose levels compared to PLA [52]. ...
... Optimizing the quality of nutrient intake (i.e., combining CHO, PRO, and/or EAA) may offer a sustained response over the postprandial period. Therefore, the potential role of mixed nutritive ingestion to increase both extracellular amino acid availability and insulin release, as well as suppressing exercise-induced cortisol secretion, should provide a potent stimulator for positive protein balance [15,22,31,54]. Such a strategy remains a realistic potential mechanism aimed at conservation of myofibrillar protein, thereby enhancing skeletal muscle growth by suppressing myofibrillar protein degradation [31]. ...
... Examining the influence of nutrient timing on protein synthesis, Tipton et al. [54] determined whether an oral amino acid-carbohydrate (EAC) supplement would be a more effective stimulator of muscle protein anabolism if given immediately before or immediately after an acute bout of lower-body resistance exercise. Ingestion of EAC (6 g EAA plus 35 g sucrose) resulted in a change in muscle protein balance from negative (net release) to positive (net uptake) in both trials. ...
Article
Full-text available
It is a common belief amongst strength and power athletes that nutritional supplementation strategies aid recovery by shifting the anabolic/catabolic profile toward anabolism. Factors such as nutrient quantity, nutrient quality, and nutrient timing significantly impact upon the effectiveness of nutritional strategies in optimizing the acute responses to resistance exercise and the adaptive response to resistance training (i.e., muscle growth and strength expression). Specifically, the aim of this review is to address carbohydrates (CHOs), protein (PRO), and/or amino acids (AAs) supplementation strategies, as there is growing evidence suggesting a link between nutrient signaling and the initiation of protein synthesis, muscle glycogen resynthesis, and the attenuation of myofibrillar protein degradation following resistance exercise. Collectively, the current scientific literature indicates that nutritional supplementation strategies utilizing CHO, PRO, and/or AA represents an important approach aimed at enhancing muscular responses for strength and power athletes, primarily increased muscular hypertrophy and enhanced strength expression. There appears to be a critical interaction between resistance exercise and nutrient–cell signaling associated with the principle of nutrient timing (i.e., pre-exercise, during, and post-exercise). Recommendations for nutritional supplementation strategies to promote muscular responses for strength and athletes are provided.
... Timing of EAA administration in relation to resistance exercise must be considered. Subjects given EAAs immediately before or after resistance exercise both realized a 130% increase in arterial and muscle phenylalanine concentrations [74]. However, the effect on net phenylalanine uptake (an indirect measure of net protein synthesis) was much greater when the drink was consumed just prior to exercise [74]. ...
... Subjects given EAAs immediately before or after resistance exercise both realized a 130% increase in arterial and muscle phenylalanine concentrations [74]. However, the effect on net phenylalanine uptake (an indirect measure of net protein synthesis) was much greater when the drink was consumed just prior to exercise [74]. It is important to note that each treatment resulted in a positive net phenylalanine balance; however, the improved amino acid delivery (blood flow X arterial EAA concentration) when consumed immediately before exercise resulted in an approximate 3-fold greater delivery of amino acids [74]. ...
... However, the effect on net phenylalanine uptake (an indirect measure of net protein synthesis) was much greater when the drink was consumed just prior to exercise [74]. It is important to note that each treatment resulted in a positive net phenylalanine balance; however, the improved amino acid delivery (blood flow X arterial EAA concentration) when consumed immediately before exercise resulted in an approximate 3-fold greater delivery of amino acids [74]. The stimulatory effect of resistance exercise on muscle blood flow, when combined with the greater amino acid delivery from consumption prior to exercise, results in a greater anabolic response in skeletal muscle. ...
Article
Full-text available
Position Statement: The International Society of Sports Nutrition (ISSN) presents this position based on a critical examination of literature surrounding the effects of essential amino acid (EAA) supplementation on skeletal muscle maintenance and performance. This position stand is intended to provide a scientific foundation to athletes, dietitians, trainers, and other practitioners as to the benefits of supplemental EAA in both healthy and resistant (aging/clinical) populations. EAAs are crucial components of protein intake in humans, as the body cannot synthesize them. The daily recommended intake (DRI) for protein was established to prevent deficiencies due to inadequate EAA consumption. The following conclusions represent the official position of the Society: 1. Initial studies on EAAs’ effects on skeletal muscle highlight their primary role in stimulating muscle protein synthesis (MPS) and turnover. Protein turnover is critical for replacing degraded or damaged muscle proteins, laying the metabolic foundation for enhanced functional performance. Consequently, research has shifted to examine the effects of EAA supplementation – with and without the benefits of exercise – on skeletal muscle maintenance and performance. 2. Supplementation with free-form EAAs leads to a quick rise in peripheral EAA concentrations, which in turn stimulates MPS. 3. The safe upper limit of EAA intake (amount), without inborn metabolic disease, can easily accommodate additional supplementation. 4. At rest, stimulation of MPS occurs at relatively small dosages (1.5–3.0 g) and seems to plateau at around 15–18 g. 5. The MPS stimulation by EAAs does not require non-essential amino acids. 6. Free-form EAA ingestion stimulates MPS more than an equivalent amount of intact protein. 7. Repeated EAA-induced MPS stimulation throughout the day does not diminish the anabolic effect of meal intake. 8. Although direct comparisons of various formulas have yet to be investigated, aging requires a greater proportion of leucine to overcome the reduced muscle sensitivity known as “anabolic resistance.” 9. Without exercise, EAA supplementation can enhance functional outcomes in anabolic-resistant populations. 10. EAA requirements rise in the face of caloric deficits. During caloric deficit, it’s essential to meet whole-body EAA requirements to preserve anabolic sensitivity in skeletal muscle.
... -Questions asked to calculate Protein Misconception Index Score.3,[33][34][35][36][37][38][39] ...
Article
Background: Protein supplements (PSs) have gained widespread popularity among non-athlete gym attendees, who often perceive them as essential tools for muscle growth and recovery. However, misinformation surrounding PSs may lead to inappropriate use and negative health consequences. This study aimed to assess whether non-athlete gym attendees using PSs have greater misconceptions than non-users while also examining the prevalence of PS consumption and gender differences. Methods: A cross-sectional study of 387 participants in the Jazan region was conducted. Customers of 10 fitness centers were screened with a questionnaire comprising questions to measure PS misconceptions. Participants were divided into PS users and non-users. Data were analyzed using descriptive statistics and the chi-square test to assess the associations between variables. An independent t-test was used to compare the PS Misconception Index Score between the two groups. Results: A total of 82.4% of non-athlete gym attendees consumed at least one PS. Our findings revealed a significant association between gender and PS utilization (P<0.001), with a higher proportion of females (90.8%) consuming PS than males (77.6%). PS users had a significantly lower PS Misconception Index Score than non-users (26.8 vs. 28.3; P=0.006), indicating that PS users had a higher number of misconceptions. The internet (41.37%) and coaches (gym instructors/trainers) (34.48%) were the most common sources of information about PSs, with muscle gain being the primary reason for consumption (82.75%). Conclusions: PS consumption is highly prevalent among non-athlete gym attendees in the Jazan region, with many individuals having misconceptions about their benefits and potential risks. Targeted educational interventions are needed to promote evidence-based knowledge about PSs for gym attendees, as well as for coaches, given that they were among the primary sources of information on supplements.
... In some studies, BCAA consumed after exercise has been reported to increase protein synthesis (Hulmi et al., 2010;Levengahen et al., 2001). Many studies have shown that pre-exercise consumption of BCAA increases protein synthesis and provides more anabolic effects by reducing protein degradation (Shimomura et al., 2010;Tipton et al., 2001;Biolo et al., 1997;Greer et al., 2007). ...
Article
Full-text available
This study investigated the effect of different amounts of Branched-Chain Amino Acids (BCAA) supplementation on recovery from eccentric exercise. Nine healthy male subjects undertook 4 trials in a randomized crossover design. Participants ingested either a three different amount (2g, 10g, and 20g) of BCAA supplement or placebo before the eccentric exercise. Muscle pain, hunger, vertical jump, balance, and sprint performance were measured before exercise, immediately after exercise, 1, 24, and 48 h. after exercise. All the variables were checked regarding their normal distribution using the Shapiro-Wilk test and data were presented as means ±SD. A repeated-measures, two factor ANOVA was used to examine differences between the four trials over time for balance, speed, vertical jump, hunger, and muscle pain change. No differences were found at baseline values for balance, velocity, vertical jump, hunger, and muscle pain for four trials (p > 0.05). While the main effect of time was statistically significant for balance, speed, vertical jump, hunger, and muscle pain (p
... Research in the early 1990s then provided some of the first experimental evidence which demonstrated that when nutrients are consumed may impact recovery potential and subsequent performance (4,5). The popularity of nutrient timing exploded when research by the late Kevin Tipton first suggested that pre-exercise feeding of essential amino acids with carbohydrate may promote higher rates of muscle protein synthesis than when those nutrients were ingested after exercise (6). The flames of this excitement were further stoked by the initial work by Cribb et al. (7) who reported that consuming nutrients in close proximity to a workout was responsible for greater increases in strength and accretion of fat-free tissues. ...
Article
Obesity is a public health crisis, with prevalence rates tripling over the past 60 y. Although lifestyle modifications, such as diet and physical activity, remain the first-line treatments, recent anti-obesity medications (AOMs) have been shown to achieve greater reductions in body weight and fat mass. However, AOMs also reduce fat-free mass, including skeletal muscle, which has been demonstrated to account for 20% to 50% of total weight loss. This can equate to ∼6 kg or 10% of total lean mass after 12–18 mo, a loss comparable to a decade of human aging. Despite questions surrounding the clinical relevance of weight loss-induced muscle loss, the importance of adopting lifestyle behaviors such as eating a protein-rich diet and incorporating regular resistance training to support skeletal muscle health, long-term weight loss maintenance, and overall well-being among AOM users should be encouraged. Herein, we provide a rationale for the clinical significance of minimizing weight-loss-induced lean mass loss and emphasize the integration of diet and physical activity into AOM clinical care. Owing to a lack of published findings on diet and physical activity supporting skeletal muscle health with AOMs, specifically, we lean on findings from large-scale clinical weight loss and diet and exercise trials to draw evidence-based recommendations for strategies to protect skeletal muscle. We conclude by identifying gaps in the literature and emphasizing the need for future experimental research to optimize skeletal muscle and whole-body health through a balance of pharmacotherapy and healthy habits.
Article
Nutritional intervention is increasingly being recognized as playing an important role in functional status. The supplementation with β‑hydroxy-β-methylbutyrate (HMB), which is a metabolite of an essential amino acid, may be an effective nutritional intervention to improve muscle strength and functionality in older adults. The aim of this narrative review was to present an updated overview of the effects of HMB supplementation in older adults, specifically on muscle strength and functional outcomes. A PubMed database search was performed and only randomized controlled trial studies were included. More than half of the 14 analyzed studies reported that HMB supplementation improved muscle strength and other functional outcomes. HMB supplementation has demonstrated some promising effects on muscle strength and functional outcomes in older adults with different conditions of health and physical activity.
Article
Full-text available
Chronic obstructive pulmonary disease (COPD) is a chronic respiratory disease that is associated with significant morbidity, mortality, and healthcare costs. The burden of respiratory symptoms and airflow limitation can translate to reduced physical activity, in turn contributing to poor exercise capacity, muscle dysfunction, and body composition abnormalities. These extrapulmonary features of the disease are targeted during pulmonary rehabilitation, which provides patients with tailored therapies to improve the physical and emotional status. Patients with COPD can be divided into metabolic phenotypes, including cachectic, sarcopenic, normal weight, obese, and sarcopenic with hidden obesity. To date, there have been many studies performed investigating the individual effects of exercise training programs as well as nutritional and pharmacological treatments to improve exercise capacity and body composition in patients with COPD. However, little research is available investigating the combined effect of exercise training with nutritional or pharmacological treatments on these outcomes. Therefore, this review focuses on exploring the potential additional beneficial effects of combinations of exercise training and nutritional or pharmacological treatments to target exercise capacity and body composition in patients with COPD with different metabolic phenotypes.
Article
Full-text available
Background: Pre-exercise protein consumption does not seem to influence substrate metabolism during exercise compared to fasted exercise, however it is unclear if the protein dose impacts on this effect. Methods: In a randomized, double-blinded within-subject design trial, healthy, active males and females (n = 15, 25 ± 5 yrs, O2peak: 47.5 ± 8.8 ml/kg/min) completed 1 h of cycling exercise at 60% peak power output 30 min after having consumed either 0, 20, or 40 g of whey protein. Indirect calorimetry was used to measure substrate oxidation during exercise and baseline and post-exercise resting energy expenditure. Blood samples were taken throughout the trials to measure metabolic responses. Free-living food intake post-trial was collected using food diaries. Results: Fat oxidation rates during exercise did not differ between the three conditions (p = 0.19) with small effect sizes between conditions (Cohen's dz: 0 vs. 20 g = 0.22, 0 vs. 40 g = 0.47, 20 vs. 40 g = 0.27). Serum insulin was higher in the protein groups vs. 0 g (p < 0.05), whereas non-esterified fatty acids were higher in the 0 g compared to 20 and 40 g (p < 0.05). Glucose was significantly lower after 15 min of exercise in 20 and 40 g vs. 0 g (p = 0.01). Resting energy expenditure was elevated post-exercise (p < 0.001), without an interaction for protein dose (p = 0.90). Post-trial free-living energy intake was not different between conditions (p = 0.31), but 24-h energy intake was significantly higher in 40 vs. 0 g (p = 0.04). Conclusion: Protein doses up to 40 g do not seem to impair fat oxidation rates during exercise compared to fasted exercise and could be considered as a nutritional strategy for exercising individuals who struggle to include fasted exercise in their training.
Thesis
Full-text available
ÖZET Kuersetin ve Resveratrol Tüketiminin Elit Adölesan Atletizm Mesafe Koşucularının Laktik Asit Düzeyleri ile Koşu Performansı Üzerine Etkilerinin İncelenmesi Bu çalışmanın amacı kuersetin ve resveratrol tüketiminin elit adölesan atletizm mesafe koşucularının laktik asit düzeyleri ile koşu performansı üzerine etkilerinin incelenmesidir. Araştırmaya Isparta ilinde bulunan elit düzeyde atletizm ile ilgilenen 4 kadın ve 4 erkek adölesan sporcu katılmıştır. Çalışmaya katılan elit adölesan atletlerin yaş ortalamaları 16,13±2,03 yıl, sporcuların vücut ağırlığı ortalamaları 52,02±6,91 kg, boy ortalamaları ise 168,3±10,61 cm olarak tespit edilmiştir. Adölesan sporcuların performanslarına kuersetin ve resveratrolün etkisini ölçmek için çalışma birer hafta ara ile 3 hafta sürmüştür. Her haftanın belirlenen 2 günü kampa alınarak ilk hafta plasebo, ikinci hafta 500 mg kuersetin ve üçüncü hafta 100 mg resveratrol takviyeleri verilmiştir. Kampın ilk günü takviyesiz 1500 m koşmaları istenmiştir. Koşu öncesi ve sonrası laktik asit ölçümü alınmış ve koşu süreleri kaydedilmiştir. İkinci günü ise takviyeler verilerek aynı ölçümler tekrarlanmıştır. Araştırmada; lactate scout, kronometre ve bioelektrik direnç ölçüm cihazı kullanılmıştır. Elde edilen verilerin analizi için Paired – T Testi ve Korelasyon Testlerinden faydalanılmıştır, anlamlılık düzeyi 0,05 olarak kabul edilmiştir. Elde edilen bulgulara bakıldığında; Kuersetin takviyesinin akut etkisinin kadın sporcularda biriken laktik asit seviyelerinde anlamlı düzeyde olduğu, erkeklerde ise koşu süresinde fark oluşturmasına rağmen istatistiksel olarak anlamlı olmadığı, resveratrol takviyesinde ise akut etkinin olmadığı dolayısıyla anlamlı bir sonuç çıkmadığı tespit edilmiştir. Sonuç olarak; kuersetin ve resveratrol müdahalelerinde yalnızca kuersetin takviyesinin kadın elit adölesan atletlerde istatistiksel olarak anlamlı fark yarattığı görülmüştür. Fakat istatistiksel olarak anlamlı çıkmasa da Atletizm spor dalı için çok önemli olan koşu süresi farklılıkları ile karşılaşılmıştır. Dolayısıyla bu çalışmanın özellikle kadın ve nispeten erkek sporcular için kuersetin takviyesinin laktik asit seviyelerini azalttığı, yorgunluğun gecikmesini sağlayarak daha iyi bir performans gösterebileceğini anlatan bir çalışma olduğu söylenebilmektedir. Anahtar Kelimler: Kuersetin, Resveratrol, Laktik Asit, Yorgunluk, Sportif Performans, Adölesan, Kadın Sporcular, Besin Takviyesi, Atletizm ABSTRACT Investigation of the Effects of Quercetin and Resveratrol Consumption on Lactic Acid Levels and Running Performance of Elite Adolescent Athletics Distance Runners The aim of this study is to investigate the effects of quercetin and resveratrol consumption on the lactic acid levels and running performance of elite adolescent athletics distance runners. 4 women and 4 male adolescent athletes interested in elite athletics in Isparta province participated in the study. The average age of elite adolescent athletes participating in the study was 16.13 ± 2.03 years, the average weight of athletes was 52.02 ± 6.91 kg, and the average height was 168.3 ± 10.61 cm. The study took 3 weeks, one week apart, to measure the effect of quercetin and resveratrol on the performance of adolescent athletes. The two days of each week were taken to the camp and the first week was given placebo, the second week was 500 mg quercetin and the third week was 100 mg resveratrol supplements. On the first day of the camp, they were asked to run 1500 m without reinforcement. Before and after the run, lactic acid measurement was taken and the running times were recorded. On the second day, the same measurements were repeated with supplements. In the study; lactate scout, stopwatch and bioelectric resistance measurement device were used. Paired - T Test and Correlation Tests were used for the analysis of the data obtained, the significance level was accepted as 0.05. Considering the findings obtained; It has been determined that the acute effect of quercetin supplement is significant in lactic acid levels accumulated in female athletes, although it is not statistically significant in males despite the difference in running time, and there is no significant result in resveratrol supplement due to the absence of acute effect. As a result; In quercetin and resveratrol interventions, only quercetin supplementation was found to make a statistically significant difference in female elite adolescent athletes. However, although not statistically significant, differences in running time, which are very important for Athletics sports branch, were encountered. Therefore, it can be said that this study is a study explaining that quercetin supplementation decreases lactic acid levels, especially for female and relatively male athletes, and provides a better performance by providing delay of fatigue. Key Words: Quercetin, Resveratrol, Lactic Acid, Fatigue, Sporty Performance, Adolescent, Women Athletes, Nutritional Supplement, Athletic
Article
Full-text available
Previous studies using indirect means to assess the response of protein metabolism to exercise have led to conflicting conclusions. Therefore, in this study we have measured the rate of muscle protein synthesis in normal volunteers at rest, at the end of 4 h of aerobic exercise (40% maximal O2 consumption), and after 4 h of recovery by determining directly the rate of incorporation of 1,2-[13C]leucine into muscle. The rate of muscle protein breakdown was assessed by 3-methylhistidine (3-MH) excretion, and total urinary nitrogen excretion was also measured. There was an insignificant increase in 3-MH excretion in exercise of 37% and a significant increase (P less than 0.05) of 85% during 4 h of recovery from exercise (0.079 +/- 0.008 vs. 0.147 +/- 0.0338 mumol.kg-1.min-1 for rest and recovery from exercise, respectively). Nonetheless, there was no effect of exercise on total nitrogen excretion. Muscle fractional synthetic rate was not different in the exercise vs. the control group at the end of exercise (0.0417 +/- 0.004 vs. 0.0477 +/- 0.010%/h for exercise vs. control), but there was a significant increase in fractional synthetic rate in the exercise group during the recovery period (0.0821 +/- 0.006 vs. 0.0654 +/- 0.012%/h for exercise vs. control, P less than 0.05). Thus we conclude that although aerobic exercise may stimulate muscle protein breakdown, this does not result in a significant depletion of muscle mass because muscle protein synthesis is stimulated in recovery.
Article
Full-text available
The effects of 12 wk of endurance training at 70% peak O2 consumption (VO2) were studied in 10 elderly (65.1 +/- 2.9 yr) and 10 young (23.6 +/- 1.8 yr) healthy men and women. Training had no effect on weight or body composition in either group. The elderly had more adipose tissue and less muscle mass than the young. Initial peak VO2 was lower in the elderly, but the absolute increase of 5.5-6.0 ml.kg-1.min-1 after training was similar for both groups. Muscle biopsies taken at rest showed that, before training, muscle glycogen stores were 61% higher in the young. Before training, glycogen utilization per joule during submaximal exercise was higher in the elderly. Glycogen stores and muscle O2 consumption increased significantly in response to training in the elderly only. After training, the proportion of energy derived from whole body carbohydrate oxidation during submaximal exercise declined in the young only. The absolute changes that training produced in peak VO2 were similar in both age groups, but the 128% increase in muscle oxidative capacity was greater in the elderly, suggesting that peripheral factors play an important role in the response of the elderly to endurance exercise.
Article
Values are presented for body constants based on a study of nine male white cadavers of normal appearance and average build. The limb data are supplemented by a further analysis of 11 upper and 41 lower limbs. Techniques used in the study form standard procedures that can be duplicated by subsequent workers. Each cadaver was measured, weighed, and somatotyped. Joints were placed in the midposition of the movement range and the body was frozen rigid. Joint angles were bisected in a systematic dismemberment procedure to produce unit segments. These segment lengths were weighed, measured for linear link dimensions, and analysed for segment volumes. The segment centers of mass were located relative to link end points as well as in relation to anatomical landmarks. Finally, each segment was dissected into its component parts and these were weighed. The specific gravity of each body part was calculated separately. Data are expressed in mean values together with standard deviations and, where available, are correlated and evaluated with other values in the literature.
Article
The present study was performed to test the hypothesis that orally administered essential amino acids, in combination with carbohydrate, will stimulate net muscle protein synthesis in resting human muscle in vivo. Four volunteers ingested 500 mL of a solution containing 13.4 g of essential amino acids and 35 g sucrose (EAA). Blood samples were taken from femoral arterial and venous catheters over a 2-hour period following the ingestion of EAA to measure arteriovenous concentrations of amino acids across the muscle. Two muscle biopsies were taken during the study, one before administration of the drink and one approximately 2 hours after consumption of EAA. Serum insulin increased from normal physiologic levels at baseline (9.2 +/- 0.8 microU/mL) and peaked (48 +/- 7.1 microU/mL) 30 minutes after EAA ingestion. Arterial essential amino acid concentrations increased approximately 100 to 400% above basal levels between 10 and 30 minutes following drink ingestion. Net nitrogen (N) balance changed from negative (-495 +/- 128 nmol/mL) prior to consumption of EAA to a peak positive value (416 +/- 140 nmol/mL) within 10 minutes of ingestion of the drink. EAA resulted in an estimated positive net N uptake of 307.3 mg N above basal levels over the 2-hour period. Muscle amino acid concentrations were similar prior to and 2 hours following ingestion of EAA. We conclude that ingestion of a solution composed of carbohydrates to stimulate insulin release and a small amount of essential amino acids to increase amino acid availability for protein synthesis is an effective stimulator of muscle protein anabolism.
Article
The goal of these studies was to evaluate acute changes in protein metabolism in skeletal muscle in response to contractile activity. Rates of protein synthesis were measured by following L-[U-14C]phenylalanine incorporation into protein in muscles of the perfused rat hindlimb at rest, during 10 min of maximal isometric muscle contractions, and during 10 min of recovery. Synthesis measurements were carried out under conditions that ensured that the specific radioactivity of the tRNA-bound precursor amino acid was equal to that of extracellular phenylalanine. Protein degradation was estimated by measuring the release of Nt-methylhistidine. Rates of synthesis were markedly inhibited in response to muscle contractions in tibialis anterior, gastrocnemius, and plantaris but were unaffected in soleus. Rates of synthesis returned toward those observed in the resting condition during the recovery period. Rates of degradation were also markedly inhibited in response to muscle contractions. Decreased rates of synthesis correlated with reduced tissue contents of ATP and creatine phosphate, a reduced ATP/ADP, and an elevated tissue content of lactate. The results demonstrate that isometric contractions in muscles consisting of a high proportion of fast glycolytic fibers result in a marked depression in rates of protein synthesis that may be due to an altered energy state.
Article
In metabolic tracer studies it is frequently useful to infuse tracers that are differently labeled variants of the same molecule. These tracers are known as isotopomers. Analysis of the enrichment of each isotopic analogue can be accomplished by gas chromatography-mass spectrometry (GC-MS). However, the raw GC-MS data must be corrected to give the information required. This paper addresses how to transform the raw GC-MS data, consisting of relative abundance ratios at specific ion masses, into relative molar ratios of tracer and tracee molecules. Several correction factors are necessary. First, the background must be measured and corrected for, since it is always present in the sample. Second, the abundances in the spectrum of the labeled molecule are different from those in the unlabeled molecule, and this proportionality "skew" is corrected. A third correction factor accounts for the overlapping spectra of two or more isotopomers that cannot be measured independently. The final correction removes the "double vision" effect that may appear in some spectra due to the presence of (M - H)+ species.
Article
The bidirectional transmembrane transport rates of leucine (Leu), valine (Val), phenylalanine (Phe), lysine (Lys), and alanine (Ala) were measured in vivo in the hindlimb muscle of five dogs and related to the rates of protein synthesis and degradation. The compartmental model was based on the systemic continuous infusion of stable isotopic tracers of the amino acids, and the measurement of the enrichment and concentration in the arterial and femoral vein plasma and the intracellular free water in muscle (obtained by biopsy). The transport rate from plasma to tissue (in micromoles per minute) was: Leu, 18.1 +/- 1.8; Val, 26.9 +/- 3.5; Phe, 10.5 +/- 1.6 Lys; 12.2 +/- 1.8; and Ala, 10.7 +/- 3.4. The transport rate from tissue to plasma (in micromoles per minute) was: Leu, 25.5 +/- 2.5; Val, 32.4 +/- 2.8; Phe, 17.0 +/- 2.8; Lys, 24.9 +/- 3.4; Ala, 34.4 +/- 9.0. When the transmembrane transport rate was normalized per unit of amino acid concentration in the source pool, we found that the transport of Leu, Val, and Phe was significantly faster (p less than .05) than the transport of Lys and Ala. The calculated rates of incorporation into hindlimb muscle protein of Phe and Lys (in micromoles per minute) were 4.2 +/- 1.3 and 19.4 +/- 5.3, respectively, and the rates of intracellular appearance from breakdown were 10.7 +/- 1.9 and 32.1 +/- 6.6, respectively. We concluded, therefore, that (1) the transmembrane amino acid transport rate can be measured in vivo in muscle with a relatively noninvasive technique, (2) in the dog hindlimb the equilibration between tissue and plasma free amino acid pool is different for each amino acid depending on the kinetics of the transmembrane transport systems, and (3) the transport rates of amino acids and their rate of appearance from protein breakdown are roughly comparable, suggesting that variations in transport rates could play a role in controlling the rate of protein synthesis.
Article
1. Anterior tibial muscle protein synthesis in seven healthy postabsorptive men was determined from increases in muscle protein bound leucine enrichment during a primed continuous infusion of l-[1−13C]leucine. Biopsies were taken 30 min after the beginning of leucine infusion (when plasma 13C enrichment was steady), 240 min later during continued fasting and again after 240 min of infusion of a mixed amino acid solution which increased plasma total amino acid concentrations by 37%. The mean enrichment of 13C in plasma α-ketoisocaproate was used as an index of the enrichment of the precursor pool for leucine metabolism. 2. Anterior tibial muscle mixed protein synthetic rate during fasting was 0.055 (sd 0.008) %/h and this increased by an average of 35% during infusion of mixed amino acid to 0.074 (sd 0.021) %/h (P < 0.05). 3. Whole-body protein breakdown (expressed as the rate of endogenous leucine appearance in plasma) was 121 (sd 8) μmol h−1 kg−1 during fasting and decreased (P < 0.01) by an average of 12% during amino acid infusion. Leucine oxidation was 18 (sd 3) μmol h−1 kg−1 during fasting and increased (P < 0.001) by 89% during amino acid infusion. Whole-body protein synthesis (non-oxidative leucine disappearance) was 104 (sd 6) μmol h−1 kg−1 during fasting and rose by 13% (P < 0.001) during mixed amino acid infusion. 4. 13C enrichment of muscle free leucine was only 61 (sd 19) % of that in plasma α-ketoisocaproate and this increased to 74 (sd 16) % (P < 0.02) during mixed amino acid infusion. 5. The results suggest that increased availability of amino acids reverses whole-body protein balance from negative to positive and a major component of this is the increase in muscle protein synthesis.
Article
Whole body protein turnover was measured in six normal adults using a model based on a primed constant infusion of [2H5]phenylalanine and, independently, by an established method of a primed constant infusion of [1-13C]leucine. Isotopic plateau in plasma was achieved within 2 h for [2H5]phenylalanine and, in four of the subjects who received a priming dose of [2H4]tyrosine, for [2H4]tyrosine. In all subjects whole body protein turnover measured with the phenylalanine model (mean protein synthesis, 2.65 +/- (SD) 0.16 g.kg-1.24 h-1; catabolism, 3.58 +/- 0.26 g.kg-1.24 h-1) was similar to that measured using the leucine model (synthesis, 3.09 +/- 0.27 g.kg-1.24 h-1; catabolism, 3.70 +/- 0.35 g.kg-1.24 h-1). Mean forearm fractional muscle protein synthesis calculated by the phenylalanine model was 0.06 +/- 0.03%/h, which compares closely with literature values derived by other methods. The phenylalanine model allows the rapid assessment of whole body and muscle protein turnover from plasma samples alone, obviating the need for measurement of expired air CO2 production or enrichment.
Article
Increasingly widespread usage of stable isotope tracers to aid clinical diagnosis and support basic research has stemmed from both advances in mass spectrometry and the availability of competitively priced labelled compounds. Stable isotopes have been used generally to investigate normal and abnormal metabolic pathways, to estimate energy expenditure and body composition and to quantitate substrate flux and oxidation rates. Despite the fact that the underlying principles relating to the use of stable isotopes for in vivo studies are straightforward, careful consideration must be given to all aspects of human studies. This review highlights some of these, including choice of label and tracer molecule, mode of tracer administration and sampling site, analytical instrumentation, interpretation of data and ethical constraints.